+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Radium-223"

Radiotheranostics Global Market Report 2024 - Product Thumbnail Image

Radiotheranostics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Radium-223 is a radioactive isotope of radium used in nuclear medicine and radiopharmacology. It is used to treat prostate cancer that has spread to the bones, as it emits alpha particles that can kill cancer cells while sparing healthy tissue. Radium-223 is administered intravenously and is typically used in combination with other treatments such as hormone therapy. Radium-223 is produced in nuclear reactors and is available in a variety of formulations. It is typically supplied as a solution in a vial, which is then further diluted for administration. The shelf life of the product is typically short, and it must be stored and handled in accordance with safety regulations. The market for Radium-223 is relatively small, but it is growing as the demand for treatments for prostate cancer increases. Companies in the market include Algeta, Bayer, and Advanced Accelerator Applications. Show Less Read more